AcuCort AB — Investor Relations & Filings

AcuCort AB is a pharmaceutical company that develops and commercializes innovative drug formulations based on well-documented substances. The company's strategy focuses on creating user-friendly products that address significant medical needs and improve upon existing treatments. Its primary product is Zeqmelit®, a fast-dissolving oral film for placement on the tongue. Zeqmelit® contains the established cortisone substance dexamethasone and is intended for the treatment of severe and acute allergic reactions. The product's key benefit is its simple and rapid administration, providing an effective alternative to conventional delivery methods.